Two glaucoma medications are being recalled, Combigan and Lumigan. The manufacturer has sent out the following message to those affected: ALLERGAN Pharmaceuticals has announced that certain lots of Combigan (brimonidine tartrate, timolol maleate) and Lumigan ( bimatoprost Combigan and Lumigan have not met the regulatory specifications for individual and total impurities and should be returned for an exchange. Patients who are taking these medications should be assured that the medications remain SAFE to use and it is essential that if you are taking them that you DO NOT STOP taking them due to the recall. If you are a patient taking these drops, contact your pharmacy to determine if you should bring in your current drops for a replacement.
Combigan( brimonidine tartrate, timolol maleate) and Lumigan ( bimatoprost) are ophthalmic solutions prescribed for the treatment of glaucoma and ocular hypertension.
The recall applies to the following bottles, according to empr.com:
Combigan 0.2%/0.5%, 5mL solution with:
NDC# 0023-9211-05; Lot# 94715; Expiration date: 1/19
NDC# 0023-9211-05; Lot# 94757; Expiration date: 2/19
NDC# 0023-9211-05; Lot# 94715A; Expiration date: 1/19
NDC# 0023-9211-05; Lot# 95297; Expiration date: 3/19
The 2.5mL solution with:
NDC# 0023-9211-03; Lot# 94659; Expiration date: 2/19
The 10mL solution with:
NDC# 0023-9211-10; Lot# 95223; Expiration date: 3/19
The 15mL solution with:
NDC# 0023-9211-15; Lot# 95220; Expiration date: 3/19
The 1 recalled lot of Lumigan 0.01%, 2.5mL, has NDC# 0023-3205-03 and Lot # 92575 with an Expiration date: 6/18.
For more information, call (800) 433-8871 or visit Allergan.com, the manufacturer of Lumigan and Combigan.